Sentence examples for basic research groups from inspiring English sources

Basic research groups might be incorporated within such well-funded consortia.

The pELMO vector (3306 bp) was constructed for the efficient and reliable cloning of PCR products; it contains two selection systems: the most common ampicillin-resistance marker generally used in basic research groups and the ccdB gene encoding a 101 amino acid toxic protein expressed by the lac promoter.

However, detailed molecular/cellular immunological data from experiments carried out independently, in the main by basic research groups unconcerned with malaria (and therefore unbiased), define a mechanism of tolerogenic induction via the skin which strongly supports this conclusion.

The French researcher, currently head of a four-laboratory basic research group at the Commissariat à l'Energie Atomique (CEA) near Paris, will take over at ESO headquarters in Garching, Germany, on 1 September.

Since 1994, she has headed the institute's basic research group, which employs some 800 physics, chemistry, and astronomy researchers.

WILLIAMS: Hewlett-Packard never really had a basic research group.

I was contacted and asked if I would be interested in trying to bootstrap up a basic research group.

He leads a basic research group on Personalized Interventional Oncotherapy at the German Cancer Research Center in Heidelberg and is the section head of Translational Medicine at the Department of Clinical Radiology and Nuclear Medicine at the Mannheim University Medical Center.

The story of the Kinect device, both its first and second generations, has been a favorite Microsoft narrative for some time, as it fuses its product teams and basic research group in a way that demonstrates the potential synergy between the two.

The NCT is a multidisciplinary clinical and basic research group as well as comprehensive cancer centre of the Medical School of the University of Heidelberg that has been founded to improve care and research for cancer patients.

This study is based on 12 semi-structured interviews with three groups of respondents: a group of oncology physicians working in a clinic at a public hospital and two groups of molecular biologists conducting basic research, one group employed at a public university and the other in a private biopharmaceutical company.